Axogen to acquire BioCircuit Technologies for $200M in cash

September 10, 2026 6:00 AM EDT Send to a Friend
Axogen, Inc. (NASDAQ: AXGN) has entered into a definitive agreement to acquire BioCircuit Technologies, Inc., a privately held medical device ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login